U.S. markets closed

TetraLogic Pharmaceuticals Corporation (TLOG)

Other OTC - Other OTC Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
0.0000-0.0001 (-99.00%)
Al cierre: 11:14AM EDT

Transacciones de miembros de la gerencia

Divisa en USD
Compras de miembros de la gerencia en los últimos 6 mesesAccionesTrans
Compras00
VentasN/D0
Acciones netas compradas (vendidas)00
Acciones totales pertenecientes a miembros de la gerenciaN/DN/D
Acciones netas compradas (vendidas) en %N/DN/D
Compras institucionales netas del trimestre anterior al últimoAcciones
Acciones netas compradas (vendidas)N/D
Cambio en acciones institucionales propias en %N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerenciaTransacciónTipoValorFechaAcciones

CLARUS LIFESCIENCES II, L. P.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 0.16 - 0.19 per share.Indirecto56,47409 feb 2016333,630

CLARUS LIFESCIENCES II, L. P.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 0.14 - 0.20 per share.Indirecto248,96705 feb 20161,415,490

CLARUS LIFESCIENCES II, L. P.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 0.17 - 0.26 per share.Indirecto71,70702 feb 2016369,132

CLARUS LIFESCIENCES II, L. P.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 0.26 - 0.30 per share.Indirecto85,97928 ene 2016311,930

PECORA ANDREW L
Director

Purchase at price 2.44 - 2.79 per share.Directo133,94410 jul 201550,000

PECORA ANDREW L
Director

Purchase at price 2.40 - 2.41 per share.Directo120,09009 jul 201550,000

SCHMITT PAUL J
Director

Purchase at price 2.33 - 2.34 per share.Indirecto23,35702 jul 201510,000

MEYERS PETE A
Chief Financial Officer

Purchase at price 4.35 per share.Directo21,75027 mar 20155,000

BUCHI J. KEVIN
Chief Executive Officer

Purchase at price 4.23 per share.Directo21,14826 mar 20155,000

BUCHI J. KEVIN
Chief Executive Officer

Purchase at price 5.04 per share.Directo25,18107 ene 20155,000

BEGLEY COLIN GLENN
Officer

Purchase at price 6.16 per share.Directo36,34410 dic 20145,900

BEGLEY COLIN GLENN
Officer

Purchase at price 6.16 per share.Directo36,96010 dic 20146,000

BUCHI J. KEVIN
Chief Executive Officer

Purchase at price 6.01 per share.Directo30,06009 dic 20145,000

MEYERS PETE A
Chief Executive Officer

Purchase at price 4.94 per share.Directo5,10804 dic 20141,034

BUCHI J. KEVIN
Chief Executive Officer

Purchase at price 4.99 per share.Directo49,90002 dic 201410,000

BEGLEY COLIN GLENN
Officer

Purchase at price 4.81 - 4.90 per share.Indirecto15,06226 nov 20143,100

RUSSELL LESLEY
Chief Operating Officer

Purchase at price 4.90 per share.Directo97,97026 nov 201420,000

BEGLEY COLIN GLENN
Officer

Purchase at price 4.84 - 4.87 per share.Directo9,70725 nov 20142,000

BUCHI J. KEVIN
Chief Executive Officer

Purchase at price 4.82 per share.Directo48,18518 nov 201410,000

PECORA ANDREW L
Director

Purchase at price 4.53 per share.Indirecto90,64017 nov 201420,000

MEYERS PETER A
Chief Financial Officer

Purchase at price 3.98 per share.Directo19,89012 nov 20145,000

BUCHI J. KEVIN
Chief Executive Officer

Purchase at price 3.93 per share.Directo39,32511 nov 201410,000

SCHMITT PAUL J
Director

Purchase at price 4.06 - 4.14 per share.Indirecto81,98210 nov 201420,000

SCHMITT PAUL J
Director

Purchase at price 7.00 per share.Indirecto3,116,25317 dic 2013445,179

SCHMITT PAUL J
Director

Conversion of Exercise of derivative security at price 0.00 - 7.00 per share.Indirecto1,391,00517 dic 20131,067,783

BUCHI J. KEVIN
Chief Executive Officer

Purchase at price 7.00 per share.Directo1,999,99817 dic 2013285,714

REED DOUGLAS
Director

Purchase at price 7.00 per share.Indirecto999,99917 dic 2013142,857

REED DOUGLAS
Director

Conversion of Exercise of derivative security at price 0.00 - 7.00 per share.Indirecto1,996,79817 dic 20131,066,885

WOODY JAMES N
Director

Purchase at price 7.00 per share.Indirecto1,829,98917 dic 2013261,427

WOODY JAMES N
Director

Conversion of Exercise of derivative security at price 0.00 - 7.00 per share.Indirecto803,09117 dic 2013740,561

AMGEN INC
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 7.00 per share.Indirecto1,904,99417 dic 2013272,142

AMGEN INC
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 0.00 - 6.40 per share.Indirecto7,30517 dic 2013718,024

GAVIN BRENDA D
Director

Conversion of Exercise of derivative security at price 7.00 per share.Indirecto337,28117 dic 201348,183

HEALTHCARE VENTURES VII L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 7.00 per share.Indirecto4,994,24117 dic 2013713,463

HEALTHCARE VENTURES VII L P
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 0.00 - 7.00 per share.Indirecto1,919,70517 dic 20131,873,003

CLARUS LIFESCIENCES II, L. P.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 7.00 per share.Indirecto9,975,42017 dic 20131,425,060

CLARUS LIFESCIENCES II, L. P.
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 0.00 - 7.00 per share.Indirecto6,122,96817 dic 20133,219,638

PECORA ANDREW L
Director

Purchase at price 7.00 per share.Indirecto185,85717 dic 201326,551

PECORA ANDREW L
Director

Conversion of Exercise of derivative security at price 0.00 - 7.00 per share.Indirecto42,24017 dic 201322,103

MEYERS PETER A
Chief Financial Officer

Purchase at price 7.00 per share.Directo999,99917 dic 2013142,857